Cell X Technologies today announced a collaboration with BioLamina to integrate BioLamina's defined laminin reagents (Biolaminin®) with Cell X's Celligent™ platform, aiming to reduce variability and ...
Our Bureau, Bengaluru Monday, September 29, 2025, 14:15 Hrs [IST] ...
ProBioGen has been selected to operate the process development and GMP production facility for Advanced Therapy Medicinal ...
Traditional microbial expression systems can be advanced through improved plasmid replication, target gene transcription, ...
Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...
The launch of the GMP PSXi013 iPSC Master Cell Bank marks a pivotal moment in Pluristyx's ongoing mission to accelerate the development of stem cell therapies. By providing a high-quality, low-passage ...
HOPEWELL, N.J., Aug. 11, 2025 /PRNewswire/ -- ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced the launch of its cGMP ...
VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade ...
MILAN & KALAMAZOO, Mich.--(BUSINESS WIRE)--Dipharma Francis S.r.l. (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, and Kalexsyn, Inc. (Kalexsyn), a world-class ...
Read here for analysis of the growth potential of MeiraGTx (MGTX) stock's gene therapy pipeline and Hologen partnership for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback